Novartis AG reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 45,440 million compared to USD 42,206 million a year ago. Net income was USD 14,850 million compared to USD 6,955 million a year ago.

Basic earnings per share from continuing operations was USD 4.13 compared to USD 2.77 a year ago. Diluted earnings per share from continuing operations was USD 4.1 compared to USD 2.76 a year ago. Basic earnings per share was USD 7.15 compared to USD 3.19 a year ago.

Diluted earnings per share was USD 7.1 compared to USD 3.17 a year ago.